Petr Kočiš

Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease

John A. Hey, Yongxin Yu, Mark Versavel et al. · Clinical Pharmacokinetics · 2017 · 123 citations · Full text

Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data

Petr Kočiš, Martin Tolar, William Sinko et al. · CNS Drugs · 2017 · 105 citations · Full text

Discovery of biologically active peptides in random libraries: solution-phase testing after staged orthogonal release from resin beads.

S. E. Salmon, Kit S. Lam, Michal Lebl et al. · Proceedings of the National Academy of Sciences · 1993 · 100 citations · Full text

Peptide Engineering, Peptide Science, Sequential Orthogonal Release +16

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

John A. Hey, Petr Kočiš, Jakub Hort et al. · CNS Drugs · 2018 · 70 citations · Full text

Multiple release of equimolar amounts of peptides from a polymeric carrier using orthogonal linkage‐cleavage chemistry

Michal Lebl, Marcel Pátek, Petr Kočiš et al. · International journal of peptide & protein research · 1993 · 68 citations

Peptide Engineering, Peptide Science, Peptide Therapeutics +19